Data / Form D filings / PharmaCCX, Inc.
PharmaCCX, Inc.: Form D filings
PharmaCCX, Inc., a technology company in Boston, MA, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on July 18, 2023, reports $5.4 million sold of a $5.4 million offering to 24 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 867 Boylston Street, PMB 211, Boston, MA, 02116
- Phone
- (508) 658-9080
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1759780
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 18, 2023 | New notice | $5,446,496 | $5,396,496 | $50,000 | 24 | Jun 26, 2023 | sec.gov |
| Mar 19, 2020 | New notice | $7,000,006 | $3,000,004 | $4,000,002 | 4 | Mar 6, 2020 | sec.gov |
| Nov 27, 2018 | New notice | $4,060,297 | $3,260,298 | $799,999 | 16 | Nov 13, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Rice | Executive Officer | |
| Nathan Sigworth | Executive Officer, Director | |
| Julia Shankar Bernstein | Director | |
| Rob Shankar Kniaz | Director | |
| Barath Shankar Subramanian | Director |
Other technology companies in Massachusetts that filed recently
- Betvisors, Inc. $150,000 · Oct 30, 2026
- RESOLV TECHNOLOGY, INC. $7.2 million · Oct 30, 2026
- Cala Systems, Inc. $2.6 million · Oct 27, 2026
- Boltz, PBC $97.4 million · Oct 22, 2026
- SpartanX Technologies, Inc. $5 million · Oct 22, 2026
- Govably, Inc. $375,000 · Oct 21, 2026
Every Form D from the week of Jul 17, 2023 · All recent filings in Massachusetts · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what PharmaCCX, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.